Flash
›
Gossamer Bio, Inc. (GOSS) Deep Dive Video
Gossamer Bio, Inc. (GOSS) Deep Dive Video
Summary
A single inhaled, disease-modifying PAH bet with a February 2026 binary catalyst—de-risked by Chiesi economics but still exposed to trial failure, competitive benchmarks, and future dilution.
View GOSS stock page
·
Read the GOSS research report
Loading the video player…